Dépôt numérique
RECHERCHER

IRF-5 Expression in Myeloid Cells Is Required for Splenomegaly in L. donovani Infected Mice

Téléchargements

Téléchargements par mois depuis la dernière année

Plus de statistiques...

Mai, Linh Thuy; Smans, Mélina; Silva-Barrios, Sasha; Fabié, Aymeric et Stäger, Simona ORCID logoORCID: https://orcid.org/0000-0001-5508-9565 (2020). IRF-5 Expression in Myeloid Cells Is Required for Splenomegaly in L. donovani Infected Mice Frontiers in Immunology , vol. 10 , nº 3071. pp. 1-9. DOI: 10.3389/fimmu.2019.03071.

[thumbnail of stager 2020-IRF-5 Expression in Myeloid Cells Is Required for Splenomegaly in L. donovani Infected Mice.pdf]
Prévisualisation
PDF - Version publiée
Disponible sous licence Creative Commons Attribution.

Télécharger (3MB) | Prévisualisation

Résumé

Persistent Leishmania donovani infection is characterized by chronic inflammation, immune suppression, and splenomegaly. We have previously reported that the transcription factor interferon regulatory factor 5 (IRF-5) is largely responsible for inducing the inflammatory response and maintaining protective Th1 cells following L. donovani inoculation in mice. However, the cellular source responsible for these effects is yet unknown. In this study, we investigated the role of IRF-5 in myeloid cells during experimental visceral leishmaniasis (VL). First, we show that the LysM-Cre mouse model is not suited for investigating gene expression in splenic myeloid cells during experimental VL. Using the Cd11c-Cre mouse model, we demonstrate that Irf5 expression in CD11c+ cells (monocytes, dendritic cells, activated macrophages) is essential for inducing splenomegaly and for recruiting myeloid cells to the spleen, but it is not required for the development or maintenance of parasite-specific IFNγ-producing CD4 T cells. CD11c-specific Irf5−/− mice are more resistant to L. donovani infection, suggesting that the induction of splenomegaly is detrimental to the host.

Type de document: Article
Mots-clés libres: IRF5; Leishmania; LysM-cre; Th1; myeloid cells; splenomegaly
Centre: Centre INRS-Institut Armand Frappier
Date de dépôt: 20 juill. 2021 04:17
Dernière modification: 16 févr. 2022 15:06
URI: https://espace.inrs.ca/id/eprint/11635

Gestion Actions (Identification requise)

Modifier la notice Modifier la notice